Helsinn Healthcare
Helsinn Healthcare, a Swiss-based pharmaceutical company, has established itself as a leader in the oncology and supportive care sectors since its founding in 1977. Headquartered in Lugano, Switzerland, Helsinn operates globally, with significant presence in Europe, North America, and Asia. The company is renowned for its innovative approach to developing high-quality products that enhance the quality of life for cancer patients, including its flagship anti-emetic treatments. With a strong commitment to research and development, Helsinn has achieved notable milestones, including strategic partnerships and a robust pipeline of therapies. Its dedication to patient-centric solutions and a focus on unmet medical needs have positioned Helsinn as a trusted name in the healthcare industry, recognised for its contributions to cancer care and supportive therapies.
DitchCarbon Score
How does Helsinn Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Helsinn Healthcare's score of 21 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Helsinn Healthcare's reported carbon emissions
In 2021, Helsinn Healthcare, headquartered in Switzerland (CH), reported total carbon emissions of approximately 3,370,000 kg CO2e. This figure includes Scope 1 emissions of about 1,175,000 kg CO2e, Scope 2 emissions of around 340,000 kg CO2e, and significant Scope 3 emissions totalling approximately 1,855,000 kg CO2e. Notably, the Scope 3 emissions were primarily driven by business travel (about 765,000 kg CO2e) and employee commuting (approximately 645,000 kg CO2e). Despite the substantial emissions reported, Helsinn Healthcare has not established specific reduction targets or initiatives as part of their climate commitments. There are no documented SBTi (Science Based Targets initiative) reduction targets or other formal climate pledges. The absence of such commitments suggests that while the company is aware of its carbon footprint, it has yet to formalise a strategy for emissions reduction. Overall, Helsinn Healthcare's emissions data reflects a comprehensive disclosure across all three scopes, indicating a commitment to transparency in their environmental impact, although further action may be necessary to align with industry standards for climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | |
|---|---|
| Scope 1 | 1,175,000 |
| Scope 2 | 340,000 |
| Scope 3 | 1,855,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Helsinn Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
